AU2005259911A1 - Topical formulations for treating allergic diseases - Google Patents

Topical formulations for treating allergic diseases Download PDF

Info

Publication number
AU2005259911A1
AU2005259911A1 AU2005259911A AU2005259911A AU2005259911A1 AU 2005259911 A1 AU2005259911 A1 AU 2005259911A1 AU 2005259911 A AU2005259911 A AU 2005259911A AU 2005259911 A AU2005259911 A AU 2005259911A AU 2005259911 A1 AU2005259911 A1 AU 2005259911A1
Authority
AU
Australia
Prior art keywords
alkyl
mmol
oxepin
pct
nhc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005259911A
Other languages
English (en)
Inventor
Mark R. Hellberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Inc
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of AU2005259911A1 publication Critical patent/AU2005259911A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/473—Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2005259911A 2004-06-28 2005-06-27 Topical formulations for treating allergic diseases Abandoned AU2005259911A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58338004P 2004-06-28 2004-06-28
US60/583,380 2004-06-28

Publications (1)

Publication Number Publication Date
AU2005259911A1 true AU2005259911A1 (en) 2006-01-12

Family

ID=35502431

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005259911A Abandoned AU2005259911A1 (en) 2004-06-28 2005-06-27 Topical formulations for treating allergic diseases

Country Status (11)

Country Link
US (1) US20050288283A1 (https=)
EP (1) EP1761259A2 (https=)
JP (1) JP2008504300A (https=)
KR (1) KR20070024618A (https=)
CN (1) CN1976694A (https=)
AU (1) AU2005259911A1 (https=)
BR (1) BRPI0512732A (https=)
CA (1) CA2569519A1 (https=)
MX (1) MXPA06014648A (https=)
WO (1) WO2006004757A2 (https=)
ZA (1) ZA200610350B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070225356A1 (en) * 2004-04-21 2007-09-27 Kyowa Hakko Kogo Co., Ltd Preventive and/or Therapeutic Agent for Chronic Sinusitis
US20060111436A1 (en) * 2004-11-23 2006-05-25 John Griffin Compositions and treatments for modulating kinase and/or HMG-CoA reductase
US8222419B2 (en) * 2006-09-29 2012-07-17 Nippon Zoki Pharmaceutical Co., Ltd. Oxepin derivative
JP5564060B2 (ja) * 2009-02-05 2014-07-30 ザック システム エス．ピー．エー． オロパタジン及び／又はその薬学的に許容され得る塩の製造方法
WO2014026611A1 (en) * 2012-08-14 2014-02-20 Huawei Technologies Co., Ltd. Rollback method and apparatus of transaction, relational database management system
CN106117176B (zh) * 2016-06-24 2018-12-11 四川大学 二氢双苯并恶庚衍生物及其组合物与应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8520662D0 (en) * 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
US4923892A (en) * 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
US5641805A (en) * 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
AU2001255675B2 (en) * 2000-05-19 2005-04-14 Alcon, Inc. Disulfide derivatives useful for treating allergic diseases
DK1289945T3 (da) * 2000-05-19 2004-11-01 Alcon Inc Anilindisulfidderivater til behandling af allergiske sygdomme
DK1284722T3 (da) * 2000-05-19 2005-09-19 Alcon Inc Sammensætninger indeholdende et benzamiddisulfidderivat til behandling af allergiske sygdomme
TWI231759B (en) * 2001-06-27 2005-05-01 Alcon Inc Olopatadine formulations for topical administration

Also Published As

Publication number Publication date
JP2008504300A (ja) 2008-02-14
CN1976694A (zh) 2007-06-06
WO2006004757A3 (en) 2006-03-09
WO2006004757A2 (en) 2006-01-12
MXPA06014648A (es) 2007-02-12
KR20070024618A (ko) 2007-03-02
EP1761259A2 (en) 2007-03-14
US20050288283A1 (en) 2005-12-29
BRPI0512732A (pt) 2008-04-08
ZA200610350B (en) 2008-12-31
CA2569519A1 (en) 2006-01-12

Similar Documents

Publication Publication Date Title
JP3048067B2 (ja) 新規方法
RU2167152C2 (ru) N-замещенные азагетероциклические карбоновые кислоты или их фармацевтически приемлемые соли, способ их получения, фармацевтическая композиция на их основе и способ ингибирования нейрогенного воспаления
DE69513219T2 (de) Kondensierte heterocyclische Verbindungen, ihre Herstellung und Anwendung
PT94026A (pt) Processo para a preparacao de um derivado de oxadiazole e de seus sais, util para o tratamento da demencia
JPWO1995019343A1 (ja) インドール誘導体
JP2010024243A (ja) 緑内障および近視を処置するためのベンゾ［ｇ］キノリン誘導体
JP2010095550A (ja) キノリン誘導体
JPH0267272A (ja) 薬理活性のあるベンゾイミダゾール誘導体
AU2005259911A1 (en) Topical formulations for treating allergic diseases
JP2007297283A (ja) 新規桂皮酸関連化合物
CA2332505A1 (en) Serotonergic 5ht7 receptor compounds for treating ocular and cns disorders
IE902750A1 (en) Coumarin derivatives, their preparation and their use in the¹treatment of cerebrovascular disorders
IE56998B1 (en) Phenothiazine derivatives
US6960579B1 (en) Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
JPH07500831A (ja) Ｃｎｓ活性テトラヒドロベンゾチエノピリジン
US4681878A (en) Fluoropheno-thiazine and pharmaceutical use
CN1142183A (zh) 治疗神经原性炎的方法
CS252489B2 (cs) Způsob výroby fenothiazinů
JPH07252149A (ja) 眼科用剤
CS252488B2 (cs) Způsob výroby fenothiazinů
PL144516B1 (en) Method of obtaining novel aromatic compounds
JP2002201177A (ja) 三環式縮合複素環誘導体、その製造法および用途
JPH09132579A (ja) ベンゾイルピペリジン誘導体およびその塩
MXPA98004749A (en) Use of compounds to reduce glucose in blood and / or inhibit the secretion, circulation or effect of antagonising peptides in the insul

Legal Events

Date Code Title Description
MK1 Application lapsed section 142(2)(a) - no request for examination in relevant period